Compositions and methods for the therapy and diagnosis of...

Details Compositions and methods for the therapy and diagnosis of... Compositions and methods for the therapy and diagnosis of...

2005-09-13

2005-09-13

Brusca, John (Department: 1631)

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

C435S006120, C435S252300, C435S320100, C435S325000, C530S300000, C536S023100, C536S024100

Reexamination Certificate

active

06943236

ABSTRACT:
Compositions and methods for the therapy and diagnosis of cancer, particularly prostate cancer, are disclosed. Illustrative compositions comprise one or more prostate-specific polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides. The disclosed compositions are useful, for example, in the diagnosis, prevention and/or treatment of diseases, particularly prostate cancer.

REFERENCES:
patent: 5786148 (1998-07-01), Bandman et al.
patent: 6329505 (2001-12-01), Xu et al.
patent: 19649207 (1998-02-01), None
patent: 317 141 (1989-05-01), None
patent: 652 014 (1995-05-01), None
patent: 679716 (1995-11-01), None
patent: 936270 (1999-08-01), None
patent: WO 93/14755 (1993-08-01), None
patent: WO 93/25224 (1993-12-01), None
patent: WO 94/09820 (1994-05-01), None
patent: WO 95/04548 (1995-02-01), None
patent: WO 95/14772 (1995-06-01), None
patent: WO 95/30758 (1995-11-01), None
patent: WO 96/21671 (1996-07-01), None
patent: WO 97/33909 (1997-09-01), None
patent: WO 98/12302 (1998-03-01), None
patent: WO 98/17687 (1998-04-01), None
patent: WO 98/20117 (1998-05-01), None
patent: WO 98/31799 (1998-07-01), None
patent: WO 98/37093 (1998-08-01), None
patent: WO 98/37093 (1998-08-01), None
patent: WO 98/37418 (1998-08-01), None
patent: WO 98/38310 (1998-09-01), None
patent: WO 98/39446 (1998-09-01), None
patent: WO 98/45435 (1998-10-01), None
patent: WO 98/50567 (1998-11-01), None
patent: WO 99/06548 (1999-02-01), None
patent: WO 99/06550 (1999-02-01), None
patent: WO 99/06552 (1999-02-01), None
patent: WO 99/25825 (1999-05-01), None
patent: WO 99/31236 (1999-06-01), None
patent: WO 99/67384 (1999-12-01), None
patent: WO 00/04149 (2000-01-01), None
patent: WO 00/53772 (2000-09-01), None
patent: WO 00/53776 (2000-09-01), None
patent: WO 00/71711 (2000-11-01), None
patent: WO 00/73801 (2000-12-01), None
patent: WO 01/16289 (2001-03-01), None
patent: WO 01/23587 (2001-04-01), None
patent: WO 01/25272 (2001-04-01), None
patent: WO 01/25446 (2001-04-01), None
patent: WO 01/34802 (2001-05-01), None
patent: WO 01/51633 (2001-07-01), None
patent: WO 01/57272 (2001-08-01), None
patent: WO 02/077243 (2002-10-01), None
Nelson, P.S. et al., “Molecular cloning and characterization of prostase, an androgen-regulated serine protease with prostate-restricted expression,”Proc. Natl. Acad. Sci. USA 96: 3114-3119, Mar. 1999.
Stephenson, S-A., “Localization of a New Prostate-specific Antigen-related Serine Protease Gene, KLK4, Is Evidence for a Expanded Human Kallikrein Gene Family Cluster on Chromosome 19q13.3-13.4,”The Journal of Biological Chemistry 274(33): 23210-23214, Aug. 13, 1999.
Yousef, G. M. et al., “Protease/KLK-L1 Is a New Member of the Human Kallikrein Gene Family, Is Expressed in Prostate and Breast Tissues, and Is Hormonally Regulated,”Cancer Research 59: 4252-4256, Sep. 1, 1999.
GenBank Database, Accession No. AAD26424, Apr. 20, 1999. Available at http://www.ncbi.nlm.nih.gov.
GenBank Database, Accession No. AAD38019, Aug. 10, 1999. Available at http://www.ncbi.nlm.nih.gov.
GenBank Database, Accession No. AAF70620, Jul. 10, 2000. Available at http://www.ncbi.nlm.nih.gov.
GenBank Database, Accession No. AAF81227, Jul. 2, 2000. Available at http://www.ncbi.nlm.nih.gov.
GenBank Database, Accession No. AAG43246, Jan. 2, 2001. Available at http://www.ncbi.nlm.nih.gov.
GenBank Database, Accession No. AAK71700, Jul. 10, 2001. Available at http://www.ncbi.nlm.nih.gov.
GenBank Database, Accession No. AAK71701, Jul. 10, 2001. Available at http://www.ncbi.nlm.nih.gov.
GenBank Database, Accession No. AAK71702, Jul. 10, 2001. Available at http://www.ncbi.nlm.nih.gov.
GenBank Database, Accession No. AAK71703, Jul. 10, 2001. Available at http://www.ncbi.nlm.nih.gov.
GenBank Database, Accession No. AAK71704, Jul. 10, 2001. Available at http://www.ncbi.nlm.nih.gov.
GenBank Database, Accession No. AAK71705, Jul. 10, 2001. Available at http://www.ncbi.nlm.nih.gov.
GenBank Database, Accession No. AAK71706, Jul. 10, 2001. Available at http://www.ncbi.nlm.nih.gov.
GenBank Database, Accession No. AF113140, Mar. 25, 1999. Available at http://www.ncbi.nlm.nih.gov.
GenBank Database, Accession No. AF126401, Jan. 2, 2001. Available at http://www.ncbi.nlm.nih.gov.
GenBank Database, Accession No. AF135023, Apr. 20, 1999. Available at http://www.ncbi.nlm.nih.gov.
GenBank Database, Accession No. AF228497, Jul. 10, 2000. Available at http://www.ncbi.nlm.nih.gov.
GenBank Database, Accession No. AF243527, Nov. 21, 2000. Available at http://www.ncbi.nlm.nih.gov.
GenBank Database, Accession No. AF259969, Jul. 2, 2000. Available at http://www.ncbi.nlm.nih.gov.
GenBank Database, Accession No. NM_004917, May 7, 1999. Available at http://www.ncbi.nlm.nih.gov.
GenBank Database, Accession No. NP_004908, May 7, 1999. Available at http://www.ncbi.nlm.nih.gov.
GenBank Database, Accession No. XP_008997, Jul. 16, 2001. Available at http://www.ncbi.nlm.nih.gov.
GenBank Database, Accession No. XP_031752, Jul. 16, 2001. Available at http://www.ncbi.nlm.nih.gov.
Ahn and Kunkel, “The structural and functional diversity of dystrophin,”Nature Genetics 3: 283-291, Apr., 1993.
Alexeyev et al., “Improved antibiotic-resistance gene cassettes and omega elements forEscherichia colivector construction and in vitro deletion/insertion mutagenesis,”Gene 160:63-67, 1995.
Berthon et al., “Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43,”Am. J. Hum. Genet. 62(6):1416-1424, Jun., 1998.
Blok et al., “Isolation of cDNAs that are differentially expressed between androgen-dependent and androgen-independent prostate carcinoma cells using differential display PCR,”The Prostate 26:213-224, 1995.
Busselmakers et al., Genbank Accession No. AF103907, Aug. 14, 2000.
Busselmakers et al., Genbank Accession No. AF103908, Aug. 14, 2000.
Cawthon et al., “cDNA sequence and genomic structure of EV12B, a gene lying within an intron of the neurofibromatosis type 1 gene,”Genomics 9:446-460, 1991.
Chu et al., “CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity,”J. Exp. Med. 186(10): 1623-1631, Nov. 17, 1997.
Coleman et al.,Fundamental Immunology, Wm. C. Brown Publishers, Dubuque, Iowa, 1989, pp. 465-466.
Database EMBL Accesion No. AA453562, Jun. 5, 1997, Hillier et al., “Homo sapienscDNA clone 788180.”
Derwent Geneseq Database, Accession No. V58522, Dec. 8, 1998.
Derwent Geneseq Database, Accession No. V61287, Jan. 6, 1999.
Duerst and Nees, “Nucleic acid characteristic of late or early passage cells immortalized by papilloma virus-and related polypeptide(s) and antibodies, used for diagnosis and treatment of cervical cancer and assessing potential for progression of cervical lesions,” Derwent World Patent Index, Accession No. 1998-121623, 1998. See also German Patent DE 19649207 C1.
El-Shirbiny, “Prostatic Specific Antigen,”Advances In Clinical Chemistry 31:99-133, 1994.
Ezzell, C., “Cancer vaccines: an idea whose time has come?”The Journal of NIH Research 7:46-49, Jan., 1995.
GenBank Accession No. AF047020, Feb. 1, 1999.
Hara et al., “Characterization of cell phenotype by a novel cDNA library subtraction system: expression of CD8α in a mast cell-derived interleukin-4-dependent cell line,”Blood 84(1):189-199, Jul. 1, 1994.
Harris et al., “Polycystic Kidney Disease 1 : identification and analysis of the primary defect,”J. Am. Soc. of Nephrol. 6:1125-1133, 1995.
Hillier et al., Genbank Accession No. AA100799, Dec. 23, 1997.
Hillier et al., Genbank Accession No. R20590, Apr. 18, 1995.
Hudson, T., Genbank Accession No. G22461, May 31, 1996.
Kroger, B. “New serine protease from human prostate, useful for identifying specific inhibitors, antibodies and probes,” Derwent World Patent Index, Accession No. 99-432218, 1999. See also European Pa

Affiliated with

Also associated with

Rating

Compositions and methods for the therapy and diagnosis of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions and methods for the therapy and diagnosis of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for the therapy and diagnosis of... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3421766